SMAD2 and breast cancer: Immunofluorescence imaging revealed an enhanced fluorescent signal of phosphorylated Smad2/Smad3 in breast cancer cells after 3oc treatment (Fig. 2C and SI Appendix, Fig. S6A), and these fluorescent signals were mainly located in the nucleus.